Immune Modulation Through Targeting PD-1/PDL-1 Signaling Pathway for the Treatment of Osteosarcoma Lung Metastastasis

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-3-s2-p218
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Mycobacterium Tuberculosis Antigens Repress Th1 Immune Response Suppression and Promotes Lung Cancer Metastasis Through PD-1/PDl-1 Signaling Pathway

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

The Role of PD-1/PD-L1 Signaling Pathway in Antitumor Immune Response

Klinicka Onkologie
Oncology
2016English

Enhancement of T Cell Immunity to Osteosarcoma Through Modulation of PD-1/PD-L1 Interactions

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2013English

Targeting the PD-1 Pathway: A Promising Future for the Treatment of Melanoma

Archives of Dermatological Research
DermatologyMedicine
2014English

Targeting the PD-1 Pathway in MSI-Stable Metastatic Colorectal Cancer

Chemotherapy: Open Access
2017English

Direct Therapeutic Targeting of Immune Checkpoint PD-1 in Pancreatic Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

The Kyn–AhR Pathway Upregulates PD-1 to Promote Tumor Immune Escape

Cancer Discovery
Oncology
2018English

Blocking the PD-1/PD-L1 Pathway in Glioma: A Potential New Treatment Strategy

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2017English

Cisplatin Contributes to Programmed Death-Ligand 1 (PD-L1) Expression in Bladder Cancer Through ERK1/2 - AP-1 Signaling Pathway

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy